to treat nonpregnant and nonlactating adults with moderate to severe acute episodic migraine when an NSAID alone is ineffective. ACP also conditionally recommends adding a triptan to acetaminophen ...

ACP also provides guidance to clinicians to consider counseling nonpregnant adults to begin treatment for acute migraine headache as soon as possible after its onset by utilizing combination ...

The FDA has granted marketing authorization to CT-132, an adjunctive, prescription digital therapeutic for the preventive ...

For nonpregnant adults who do not respond adequately to a nonsteroidal anti-inflammatory drug, ACP recommends the addition of a triptan to treat moderate-to-severe acute episodic migraine.

has approved a novel formulation combining rizatriptan and the nonsteroidal anti-inflammatory drug meloxicam for the acute treatment of migraine in adults. Migraines and headaches are common ...

The guidelines were designed for physicians and other clinicians and related to adults with acute episodic migraine headache (defined as one to 14 headache days per month) managed in outpatient ...